Trimetazidine dihydrochloride
Trimetazidine dihydrochloride (Yoshimilon, Kyurinett, Vastarel F) is a kind of drug for treatment of chronic ischemic disorders. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, known as fatty acid oxidation inhibitor.
| Trivial name | Yoshimilon, Kyurinett, Vastarel F |
| Catalog Number | S4543 |
| Molecular Formula | C14H22N2O3.2HCl |
| CAS# | 13171-25-0 |
| Inchi | InChI=1S/C14H22N2O3.2ClH/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16;;/h4-5,15H,6-10H2,1-3H3;2*1H |
| Inchi Key | VYFLPFGUVGMBEP-UHFFFAOYSA-N |
| SMILES | COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC.Cl.Cl |
| Size | 500mg |
| Supplier Page | http://www.selleckchem.com/products/trimetazidine-dihydrochloride.html |
| Additional Information | https://file.selleck.cn/downloads/struct/trimetazidine-dihydrochloride-chemical-structure-s4543.gif |